rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Patrick J. Balthrop

Director

Company insider

Files Form 4 as: Director, MaxCyte; Director, Oxford Immunotec Global; Director, Personalis; President & CEO, Luminex.

In numbers

Trades disclosed
111
Buys
3
Sells
10
Bought
$235K
Sold
$6.1M
Companies
4
Companies where not an officer
3
First trade
5 Apr 2006
Last trade
17 Jun 2026
Last filed
22 Jun 2026

Companies traded

Where they are an officer
LuminexDirector, Officer · last 15 May 20142 buys · 10 sells
Everywhere else they filed: board seats, 10% stakes, other companies
MXCT MaxCyteDirector · Life-science tools · last 17 Jun 20260 buys · 0 sells
Oxford Immunotec GlobalDirector · last 8 Mar 20211 buy · 0 sells
PSNL PersonalisDirector · Diagnostics & Labs · last 15 May 20200 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Jun 2026filed 22 Jun 2026MXCT MaxCyteLife-science toolsSEC FORM 4 Code A—30,421 at $0.00filing
17 Jun 2026filed 22 Jun 2026MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—49,579 at $0.00filing
17 Jun 2026filed 22 Jun 2026MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—49,579 at $0.00filing
17 Jun 2026filed 22 Jun 2026MXCT MaxCyteLife-science toolsSEC FORM 4 Code A—30,421 at $0.00filing
18 Jun 2025filed 23 Jun 2025MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—50,790 at $0.00filing
18 Jun 2025filed 23 Jun 2025MXCT MaxCyteLife-science toolsSEC FORM 4 Code A—29,210 at $0.00filing
11 Jun 2024filed 13 Jun 2024MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—40,701 at $0.00filing
11 Jun 2024filed 13 Jun 2024MXCT MaxCyteLife-science toolsSEC FORM 4 Code A—21,367 at $0.00filing
22 Jun 2023filed 23 Jun 2023MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—50,000 at $0.00filing
30 Nov 2022filed 1 Dec 2022MXCT MaxCyteoption or derivative · Life-science toolsSEC FORM 4 Code A—100,000 at $0.00filing
8 Mar 2021filed 12 Mar 2021Oxford Immunotec GlobalSEC FORM 4 Code D$178K8,081 at $22.00filing
8 Mar 2021filed 12 Mar 2021Oxford Immunotec Globaloption or derivativeSEC FORM 4 Code D$39K3,728 at $10.38filing
8 Mar 2021filed 12 Mar 2021Oxford Immunotec Globaloption or derivativeSEC FORM 4 Code D$155K14,914 at $10.38filing
8 Mar 2021filed 12 Mar 2021Oxford Immunotec Globaloption or derivativeSEC FORM 4 Code D$100K7,457 at $13.35filing
8 Mar 2021filed 12 Mar 2021Oxford Immunotec Globaloption or derivativeSEC FORM 4 Code D$56K7,457 at $7.54filing
8 Mar 2021filed 12 Mar 2021Oxford Immunotec Globaloption or derivativeSEC FORM 4 Code D$56K7,457 at $7.51filing
8 Mar 2021filed 12 Mar 2021Oxford Immunotec Globaloption or derivativeSEC FORM 4 Code D$56K7,457 at $7.56filing
8 Mar 2021filed 12 Mar 2021Oxford Immunotec Globaloption or derivativeSEC FORM 4 Code D$86K9,494 at $9.04filing
24 Jun 2020filed 26 Jun 2020Oxford Immunotec Globaloption or derivativeSEC FORM 4 Code A—9,494 at $0.00filing
24 Jun 2020filed 26 Jun 2020Oxford Immunotec GlobalSEC FORM 4 Code A—4,081 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed13

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.